PSMG3-AS1
Putative uncharacterized protein PSMG3-AS1
Also known as: K1908_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for PSMG3-AS1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
264 residues, UniProt reviewed canonical sequence.
>Q96PY0|PSMG3-AS1
1 MMDCTWTLPG MRATWQPAPF LPWDQTPWRV SFSWSPVLLA WGGVWSGEAH PCAHVLRPPA
61 SPCPPRPRRG CGDSGSSGMA QRAQAGSNQS RGKCGRDGRC PPRSSPGAPE AAERVESAET
121 RGPGKSWILS PSSMSEPRRG KARRSPGRRR HPHSSFPQAS SPSSPSRRET IPQVQSSGVP
181 GAMSPEQTLF SRSPRGLSHL GQSLCRTVKE SEAQRGKTMP PGSHSPSGAG QGRTARKGPA
241 REEIPSSDSS AKPSVYPHPH LTATLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSMG3-AS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSMG3-AS1 as an antibody target. Whether an autoantibody or antibody against PSMG3-AS1 could matter depends on whether native PSMG3-AS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSMG3-AS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSMG3-AS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...